Applications for San Francisco (Batch 12) extended through September 15th, 2021!

Learn more about investing in Brightcure Ltd.

Our team will get back to you soon to follow up on your inquiry.
Brightcure Ltd.
Next-generation microbiome femcare for a healthy urinary tract
Founded
2019
Employees*
1-10
Funding to Date*
$254.5K
Website
bcure.co.uk
Chiara Heide, Ph.D., CEO
By fighting these bad bacteria, it gives the good bacteria room to colonize the vaginal area. This is what balances and promotes the good bacteria in the intimate area.
50% of women will get a urinary tract infection during their lifetime.

BrightCure’s bioactive ingredient continuously protects, restores and balances your intimate skin. Our products calm your urogenital area which can be irritated and damaged by antibiotic therapies and harmful bacteria living in your gut and colonizing women’s intimate area. Unhealthy food, irritation, and changes in pH lead to reduced urogenital comfort making it easier for bad bacteria to grow on your skin.

BrightCure’s ACTIVE COMPONENT kills the harmful bacteria and activates the skin’s natural ability to repair and protect itself, thereby boosting your natural immune system to promote a healthy woman’s intimate microbiome.

Similar Companies

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.